new article, page-25

Thank you for the link Kenny, but dear oh dear.

	Study Status:	This study is currently recruiting participants.
1	Estimated Study Completion Date:	March 2014
2	Estimated Primary Completion Date:	July 2013 (Final data collection date for primary outcome measure)

Still recruiting patients?

Can anyone provide us with:

• the number of actual participants still required?
• average number of participants recruited each month
• time taken with participants to gather the required data

Knowing these three variables above, it would easy to estimate when the trail will really conclude.

March 2014 has obviously come and gone, and the trial is still on-going.
It's only a few days away from being August where I am.

Since 2008, there is a history of announcements from the company that mention the delays in trial being frustrating.

Once thing that remains totally unexplained is this:

IF ReCell is so wonderful AND it is approaching the end of the FDA trial, then WHY isn't some speculative premium already built into the share price???

Why does the broader market (ie; everybody except a tiny number of HC posters) steer away from AVH with a barge pole?

IMO, there is something not right about this, and caution is warranted.
As always, please do your own research, and read beyond the cuts & pastes.